These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33625290)

  • 1. COVID-19 reinfection in two children with cancer.
    Yadav SP; Wadhwa T; Thakkar D; Kapoor R; Rastogi N; Sarma S
    Pediatr Hematol Oncol; 2021 May; 38(4):403-405. PubMed ID: 33625290
    [No Abstract]   [Full Text] [Related]  

  • 2. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
    Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
    Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization of Vertebral Body Deformities in Childhood by MRI in a Boy with ALL.
    Zhang XD; Madjidyar J; Peters S
    Rofo; 2019 Aug; 191(8):752-753. PubMed ID: 30900230
    [No Abstract]   [Full Text] [Related]  

  • 4. Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia.
    Lauten M; Güttel C; Härtel C; Erdlenbruch B
    Klin Padiatr; 2014 May; 226(3):188-9. PubMed ID: 24158893
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular genetic detection of minimal residual disease (MRD) in children with acute lymphoblastic leukemia].
    Koehler R; Bartram CR
    Klin Padiatr; 2013 May; 225 Suppl 1():S40-4. PubMed ID: 23700054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration.
    Nowak-Göttl U; Ahlke E; Fleischhack G; Schwabe D; Schobess R; Schumann C; Junker R
    Blood; 2003 Apr; 101(7):2529-33. PubMed ID: 12517808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-asparaginase-induced Parotitis in an Elderly Patient with Acute Lymphoblastic Leukemia.
    Saburi M; Ogata M; Soga Y; Itani K; Kohno K; Nakayama T
    Intern Med; 2020 Jul; 59(14):1745-1748. PubMed ID: 32296003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
    Möricke A; Lauten M; Beier R; Odenwald E; Stanulla M; Zimmermann M; Attarbaschi A; Niggli F; Schrappe M
    Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN abnormalities predict poor outcome in children with T-cell acute lymphoblastic leukemia treated according to ALL IC-BFM protocols.
    Szarzyńska-Zawadzka B; Kunz JB; Sędek Ł; Kosmalska M; Zdon K; Biecek P; Bandapalli OR; Kraszewska-Hamilton M; Jaksik R; Drobna M; Kowalczyk JR; Szczepański T; Van Vlierberghe P; Kulozik AE; Witt M; Dawidowska M
    Am J Hematol; 2019 Apr; 94(4):E93-E96. PubMed ID: 30614545
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of treatment of children with acute lymphoblastic leukemia with a modified BFM protocol].
    Janić D; Dokmanović L; Jovanović N; Skorić D; Lazić J
    Srp Arh Celok Lek; 2004 Oct; 132 Suppl 1():17-22. PubMed ID: 15615459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The results of a multicenter trial of acute lymphoblastic leukemia treatment on ALL-MB 91/ALL-BFM 90m in children: analysis of efficacy and toxicity].
    Karachunskiĭ AI; Miakova NV; Rumiantseva IuV; Timakov AM; Makhortykh TZh; Fechina LG; Shamardina AV; Dudkin SA; Lebedev VV; Varfolomeeva SR; Timofeeva VN; Herold R; Stakelberg A; Henze G; Rumiantsev AG
    Ter Arkh; 2007; 79(7):19-26. PubMed ID: 17802785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of modified LSA2L2 therapy in children with non-Hodgkin's lymphoma].
    Shitara T; Kuribayashi T; Oshima Y; Suetake N; Hiraishi Y
    Rinsho Ketsueki; 1984 Oct; 25(10):1594-9. PubMed ID: 6549186
    [No Abstract]   [Full Text] [Related]  

  • 14. The incidence of symptomatic osteonecrosis is similar between Japanese children and children in Western countries with acute lymphoblastic leukaemia treated with a Berlin-Frankfurt-Münster (BFM)95-based protocol.
    Moriya K; Imamura T; Katayama S; Kaino A; Okamoto K; Yokoyama N; Uemura S; Kitazawa H; Sekimizu M; Hiramatsu H; Usami I; Ishida H; Hasegawa D; Hama A; Moriya-Saito A; Sato A; Sasahara Y; Suenobu S; Horibe K; Hara J;
    Br J Haematol; 2022 Mar; 196(5):1257-1261. PubMed ID: 34879431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens.
    Brodtman DH; Rosenthal DW; Redner A; Lanzkowsky P; Bonagura VR
    J Pediatr; 2005 May; 146(5):654-61. PubMed ID: 15870670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
    Patte C; Auperin A; Michon J; Behrendt H; Leverger G; Frappaz D; Lutz P; Coze C; Perel Y; Raphaël M; Terrier-Lacombe MJ;
    Blood; 2001 Jun; 97(11):3370-9. PubMed ID: 11369626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Risk Factors for Hypertension During Childhood Acute Lymphoblastic Leukemia Therapy.
    Malhotra P; Kapoor G; Jain S; Garg B
    Indian Pediatr; 2018 Oct; 55(10):877-879. PubMed ID: 29941701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Half-and-half nails in a pediatric patient after chemotherapy.
    Afsar FS; Ozek G; Vergin C
    Cutan Ocul Toxicol; 2015; 34(4):350-1. PubMed ID: 25597374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma.
    Cai Y; Sun XF; Yan SL; Zhen ZJ; Xia Y; Ling JY
    Chin J Cancer; 2010 Mar; 29(3):312-6. PubMed ID: 20193116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy.
    Matsushima S; Kobayashi R; Sano H; Hori D; Yanagi M; Kodama K; Suzuki D; Kobayashi K
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28763. PubMed ID: 33047887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.